A Phase I Study to Evaluate the Safety and Immunogenicity of PnuBioVax

Clinical trial NCT02572635 · COMPLETED

Trial details

NCT number: NCT02572635
Sponsor: ImmunoBiology Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pneumococcal Infection

Start date: 2015-10-01
Primary completion: 2016-09-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.